JP2002509876A5 - - Google Patents

Download PDF

Info

Publication number
JP2002509876A5
JP2002509876A5 JP2000540812A JP2000540812A JP2002509876A5 JP 2002509876 A5 JP2002509876 A5 JP 2002509876A5 JP 2000540812 A JP2000540812 A JP 2000540812A JP 2000540812 A JP2000540812 A JP 2000540812A JP 2002509876 A5 JP2002509876 A5 JP 2002509876A5
Authority
JP
Japan
Prior art keywords
phospholipid
block copolymer
surface modifier
charged surface
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000540812A
Other languages
English (en)
Japanese (ja)
Other versions
JP4709378B2 (ja
JP2002509876A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/006746 external-priority patent/WO1999049846A2/en
Publication of JP2002509876A publication Critical patent/JP2002509876A/ja
Publication of JP2002509876A5 publication Critical patent/JP2002509876A5/ja
Application granted granted Critical
Publication of JP4709378B2 publication Critical patent/JP4709378B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000540812A 1998-03-30 1999-03-29 水不溶性物質のマイクロ粒子を製造するための組成物及び方法 Expired - Fee Related JP4709378B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7980998P 1998-03-30 1998-03-30
US60/079,809 1998-03-30
PCT/US1999/006746 WO1999049846A2 (en) 1998-03-30 1999-03-29 Compositions containing microparticles of water-insoluble substances and method for their preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010232130A Division JP5539839B2 (ja) 1998-03-30 2010-10-15 水不溶性物質のマイクロ粒子を製造するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2002509876A JP2002509876A (ja) 2002-04-02
JP2002509876A5 true JP2002509876A5 (cg-RX-API-DMAC7.html) 2006-04-27
JP4709378B2 JP4709378B2 (ja) 2011-06-22

Family

ID=22152962

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000540812A Expired - Fee Related JP4709378B2 (ja) 1998-03-30 1999-03-29 水不溶性物質のマイクロ粒子を製造するための組成物及び方法
JP2010232130A Expired - Fee Related JP5539839B2 (ja) 1998-03-30 2010-10-15 水不溶性物質のマイクロ粒子を製造するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010232130A Expired - Fee Related JP5539839B2 (ja) 1998-03-30 2010-10-15 水不溶性物質のマイクロ粒子を製造するための組成物及び方法

Country Status (14)

Country Link
US (1) US6387409B1 (cg-RX-API-DMAC7.html)
EP (1) EP1067914B1 (cg-RX-API-DMAC7.html)
JP (2) JP4709378B2 (cg-RX-API-DMAC7.html)
KR (1) KR100628341B1 (cg-RX-API-DMAC7.html)
CN (1) CN1303278B (cg-RX-API-DMAC7.html)
AT (1) ATE318132T1 (cg-RX-API-DMAC7.html)
AU (1) AU761205B2 (cg-RX-API-DMAC7.html)
CA (1) CA2326456C (cg-RX-API-DMAC7.html)
DE (1) DE69929959T2 (cg-RX-API-DMAC7.html)
ES (1) ES2257041T3 (cg-RX-API-DMAC7.html)
IL (3) IL138765A0 (cg-RX-API-DMAC7.html)
SE (1) SE0003429L (cg-RX-API-DMAC7.html)
TW (1) TWI267383B (cg-RX-API-DMAC7.html)
WO (1) WO1999049846A2 (cg-RX-API-DMAC7.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
AU761205B2 (en) * 1998-03-30 2003-05-29 Skyepharma Canada Inc. Composition and method of preparing microparticles of water-insoluble substances
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU764001B2 (en) 1998-05-29 2003-08-07 Skyepharma Canada Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
IL143196A0 (en) * 1998-11-20 2002-04-21 Rtp Pharma Inc Method of preparing stable suspensions of insoluble microparticles
SK288117B6 (sk) 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
WO2001021154A2 (en) * 1999-09-21 2001-03-29 Rtp Pharma Inc. Surface modified particulate compositions of biologically active substances
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
US7276249B2 (en) * 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6607784B2 (en) 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
US20070264348A1 (en) * 2002-05-24 2007-11-15 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
CN1243538C (zh) * 2002-11-21 2006-03-01 武汉利元亨药物技术有限公司 熊果酸豆磷脂纳米粒冻干粉针及制备方法
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US6931888B2 (en) * 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US20040178135A1 (en) * 2003-03-13 2004-09-16 Beplate Douglas K. Filtering device incorporating nanoparticles
AU2004240640A1 (en) * 2003-05-19 2004-12-02 Baxter International Inc. Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers
JP2007509981A (ja) * 2003-10-31 2007-04-19 テバ ファーマシューティカル インダストリーズ リミティド 薬物デリバリー用ナノ粒子
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
EP1706095B1 (en) 2004-01-20 2008-12-24 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050170063A1 (en) * 2004-01-29 2005-08-04 Lalit Chordia Production of powder and viscous material
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
AU2005271700B2 (en) * 2004-07-12 2010-11-11 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
EP1815869A4 (en) * 2004-11-24 2011-04-06 Nanocarrier Co Ltd PROCESS FOR CHANGING THE MORPHOLOGY OF BLOCK COPOLYMERS
JP2008543842A (ja) * 2005-06-14 2008-12-04 バクスター インターナショナル インコーポレイテッド 薬物−薬物相互作用を最小にするための薬学的処方物
WO2007008697A2 (en) * 2005-07-08 2007-01-18 University Of Chicago Compositions and methods for refolding of denatured proteins
AU2006315177A1 (en) * 2005-11-15 2007-05-24 Baxter Healthcare S.A. Compositions of lipoxygenase inhibitors
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
LT2170279T (lt) * 2007-07-31 2018-03-12 Otsuka Pharmaceutical Co., Ltd. Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
JP2013540827A (ja) 2010-10-29 2013-11-07 ウエスタン ユニバーシティ オブ ヘルス サイエンシズ 三種混合製剤
US20140000540A1 (en) * 2012-06-27 2014-01-02 Shell Oil Company Fuel and engine oil composition and its use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091187A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
MX9201782A (es) 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
US5298262A (en) 1992-12-04 1994-03-29 Sterling Winthrop Inc. Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
US5340564A (en) 1992-12-10 1994-08-23 Sterling Winthrop Inc. Formulations comprising olin 10-G to prevent particle aggregation and increase stability
US5336507A (en) 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
US5326552A (en) 1992-12-17 1994-07-05 Sterling Winthrop Inc. Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5569448A (en) 1995-01-24 1996-10-29 Nano Systems L.L.C. Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
WO1996024332A1 (en) * 1995-02-06 1996-08-15 Nanosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
ES2306452T3 (es) * 1995-10-17 2008-11-01 Jagotec Ag Aporte de farmacos insolubles.
US5686133A (en) 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
RU2186562C2 (ru) * 1996-08-22 2002-08-10 Ресеч Трайангл Фармасьютикалс Лтд. Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
WO1999029300A1 (en) * 1997-12-10 1999-06-17 Rtp Pharma Inc. Self-emulsifying fenofibrate formulations
AU761205B2 (en) * 1998-03-30 2003-05-29 Skyepharma Canada Inc. Composition and method of preparing microparticles of water-insoluble substances
EP2733235B1 (en) * 2011-09-30 2017-05-03 JX Nippon Mining & Metals Corporation Sputtering target and manufacturing method therefor

Similar Documents

Publication Publication Date Title
JP2011037889A5 (cg-RX-API-DMAC7.html)
US6790460B2 (en) Biodegradable bioadhesive controlled release system of nano-particles for oral care products
JP3218637B2 (ja) 安定なリポソーム水懸濁液
EP0771566B1 (en) Stabilization of colloidal systems by the formation of ionic lipid-polysaccharide complexes
JP4709378B2 (ja) 水不溶性物質のマイクロ粒子を製造するための組成物及び方法
US5962015A (en) Stabilized liposomes
JP2021522163A5 (cg-RX-API-DMAC7.html)
ATE238768T1 (de) Grosse poröse partikel ausgestossen von einem inhalator
IL278079B2 (en) Inhalable liposomal sustained release composition for use in treating pulmonary diseases
CA2063862A1 (en) Topical preparation containing a suspension of solid lipid particles
JP2003507412A5 (cg-RX-API-DMAC7.html)
JP2003513911A5 (cg-RX-API-DMAC7.html)
PT954282E (pt) Preparacao de particulas para inalacao
JP2004508423A (ja) ホスファチジルセリンを保有するアポトーシス擬態体及び医療用治療におけるその使用
JP2002512947A5 (cg-RX-API-DMAC7.html)
JP2002501885A5 (cg-RX-API-DMAC7.html)
EP0179237A1 (en) Process for preparing liposome compositions
US10568975B2 (en) Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
JP2007513180A5 (cg-RX-API-DMAC7.html)
Chimote et al. Evaluation of antitubercular drug‐loaded surfactants as inhalable drug‐delivery systems for pulmonary tuberculosis
JP5225835B2 (ja) ナノ粒子被覆カプセルの乾燥製剤
WO2003015753A1 (fr) Preparations de liposomes
JPWO1991007973A1 (ja) 脂肪乳剤
WO2005092389A1 (ja) 複合粒子および被覆複合粒子
JP2023503910A (ja) 薬物送達用ナノ粒子組成物製造用キット